It has been shown earlier that VGB3 is a dual VEGFR1/R2 blockading peptide that inhibit growth and metastasis of breast tumors through abrogation of angiogenesis as well as inhibition of proliferation and migration, and induction of apoptosis in 4T1 tumor cells. Here, FLT1 is linked to breast neoplasm.